Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human BMAL1 ELISA Kit (AC2818)
Cat.#: ASET-1407
Specifications
Description Human BMAL1 ELISA Kit allows for the in vitro quantitative determination of human BMAL1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1251 Human PICALM ELISA Kit (AC2662) Quantitative inquiry ASET-1607 Human Glutamine Synthetase ELISA Kit (AC3018) Quantitative inquiry ASET-1181 Rat BACE1 ELISA Kit (AC2592) Quantitative inquiry ASET-1134 Human NRXN3 ELISA Kit (AC2545) Quantitative inquiry ASET-1137 Rat SOX9 ELISA Kit (AC2548) Quantitative inquiry ASET-2421 Human Adiponectin ELISA Kit (AC3832) Quantitative inquiry ASET-1821 Human Adenosine A1 Receptor ELISA Kit (AC3232) Quantitative inquiry ASET-1639 Human Ataxin 1 ELISA Kit (AC3050) Quantitative inquiry ASET-2041 Rabbit BDNF ELISA Kit (AC3452) Quantitative inquiry ASET-1039 Human P2Y2 ELISA Kit (AC2450) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket